| Entry |
|
|---|
| Name |
Norfenefrine (INN) |
|---|
| Formula |
C8H11NO2
|
|---|
| Exact mass |
153.0790
|
|---|
| Mol weight |
153.18
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Cardiovascular agent
DG01703 Cardiotonic
DG01702 Phenethylamine cardiotonic
DG01456 Adrenergic receptor agonist
DG01450 alpha-Adrenergic receptor agonist
DG01448 alpha1-Adrenergic receptor agonist
|
|---|
| Remark |
|
|---|
| Efficacy |
Cardiotonic |
|---|
| Comment |
Phenethylamine derivative
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C01 CARDIAC THERAPY
C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
C01CA Adrenergic and dopaminergic agents
C01CA05 Norfenefrine
D08286 Norfenefrine (INN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01703 Cardiotonic
DG01702 Phenethylamine cardiotonic
DG00214 Norfenefrine
D08286 Norfenefrine
DG01456 Adrenergic receptor agonist
DG01450 alpha-Adrenergic receptor agonist
DG01448 alpha1-Adrenergic receptor agonist
DG00214 Norfenefrine
D08286 Norfenefrine
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
ADRA1
D08286 Norfenefrine (INN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01703 Cardiotonic
DG01702 Phenethylamine cardiotonic
DG00214 Norfenefrine
DG01456 Adrenergic receptor agonist
DG01450 alpha-Adrenergic receptor agonist
DG01448 alpha1-Adrenergic receptor agonist
DG00214 Norfenefrine
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 11
1 C8y C 13.5100 -27.2300
2 C8x C 13.5100 -28.6300
3 C8x C 14.7224 -29.3300
4 C8x C 15.9349 -28.6300
5 C8y C 15.9349 -27.2300
6 C8x C 14.7224 -26.5300
7 C1c C 17.1660 -26.5190
8 C1b C 18.3712 -27.2147
9 O1a O 17.1657 -25.1301
10 N1a N 19.5535 -26.5319
11 O1a O 12.2976 -26.5300
BOND 11
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 5 7 1
8 7 8 1
9 7 9 1
10 8 10 1
11 1 11 1
|
|---|
